New cream shows promise for clearing stubborn eczema

NCT ID NCT05032859

Completed Disease control Sponsor: Organon and Co Source: ClinicalTrials.gov ↗

Summary

This study tested a once-daily cream called tapinarof for people with moderate to severe eczema. Over 400 children and adults used the cream or a placebo for 8 weeks to see if it could clear or nearly clear their skin. The main goal was to see if the active cream was more effective and safe than the placebo cream.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Dermanvant Investigative Site

Brooklyn, New York, 11203, United States
Dermavant Investigative Site

Birmingham, Alabama, 35244, United States
Dermavant Investigative Site

Scottsdale, Arizona, 85255, United States
Dermavant Investigative Site

Scottsdale, Arizona, 85260, United States
Dermavant Investigative Site

Fort Smith, Arkansas, 72916, United States
Dermavant Investigative Site

Cerritos, California, 90702, United States
Dermavant Investigative Site

Huntington Beach, California, 92647, United States
Dermavant Investigative Site

Lancaster, California, 93534, United States
Dermavant Investigative Site

Long Beach, California, 90806, United States
Dermavant Investigative Site

Los Angeles, California, 90045, United States
Dermavant Investigative Site

San Diego, California, 92123, United States
Dermavant Investigative Site

San Francisco, California, 94115, United States
Dermavant Investigative Site

Santa Ana, California, 92701, United States
Dermavant Investigative Site

Santa Monica, California, 90404, United States
Dermavant Investigative Site

Boca Raton, Florida, 33428, United States
Dermavant Investigative Site

Delray Beach, Florida, 33484, United States
Dermavant Investigative Site

Jacksonville, Florida, 32256, United States
Dermavant Investigative Site

Miami, Florida, 33165, United States
Dermavant Investigative Site

Miami, Florida, 33173, United States
Dermavant Investigative Site

Miami Lakes, Florida, 33014, United States
Dermavant Investigative Site

Tampa, Florida, 33607, United States
Dermavant Investigative Site

Snellville, Georgia, 30078, United States
Dermavant Investigative Site

Evansville, Indiana, 47715, United States
Dermavant Investigative Site

Overland Park, Kansas, 66210, United States
Dermavant Investigative Site

Lexington, Kentucky, 40517, United States
Dermavant Investigative Site

Louisville, Kentucky, 40241, United States
Dermavant Investigative Site

Baton Rouge, Louisiana, 70808, United States
Dermavant Investigative Site

Baton Rouge, Louisiana, 70809, United States
Dermavant Investigative Site

New Orleans, Louisiana, 70115, United States
Dermavant Investigative Site

Rockville, Maryland, 20850, United States
Dermavant Investigative Site

Detroit, Michigan, 48202, United States
Dermavant Investigative Site

Lincoln, Nebraska, 68516, United States
Dermavant Investigative Site

Omaha, Nebraska, 68114, United States
Dermavant Investigative Site

Las Vegas, Nevada, 89148, United States
Dermavant Investigative Site

East Windsor, New Jersey, 08520, United States
Dermavant Investigative Site

Watertown, New York, 13601, United States
Dermavant Investigative Site

Charlotte, North Carolina, 28277, United States
Dermavant Investigative Site

Dayton, Ohio, 45414, United States
Dermavant Investigative Site

Mason, Ohio, 45040, United States
Dermavant Investigative Site

Mayfield Heights, Ohio, 44124, United States
Dermavant Investigative Site

Tulsa, Oklahoma, 74114, United States
Dermavant Investigative Site

Medford, Oregon, 97504, United States
Dermavant Investigative Site

Portland, Oregon, 97210, United States
Dermavant Investigative Site

Portland, Oregon, 97239, United States
Dermavant Investigative Site

East Greenwich, Rhode Island, 02818, United States
Dermavant Investigative Site

Anderson, South Carolina, 29621, United States
Dermavant Investigative Site

North Charleston, South Carolina, 29420, United States
Dermavant Investigative Site

Spartanburg, South Carolina, 29303, United States
Dermavant Investigative Site

Memphis, Tennessee, 38119, United States
Dermavant Investigative Site

Bellaire, Texas, 77401, United States
Dermavant Investigative Site

Dripping Springs, Texas, 78620, United States
Dermavant Investigative Site

Grapevine, Texas, 76051, United States
Dermavant Investigative Site

Houston, Texas, 77004, United States
Dermavant Investigative Site

Houston, Texas, 77061, United States
Dermavant Investigative Site

San Antonio, Texas, 78213, United States
Dermavant Investigative Site

Webster, Texas, 77598, United States
Dermavant Investigative Site

Spokane, Washington, 99202, United States
Dermavant Investigative Site

Surrey, British Columbia, V3R 6A7, Canada
Dermavant Investigative Site

Barrie, Ontario, L4M 7G1, Canada
Dermavant Investigative Site

Markham, Ontario, L3P 1X3, Canada
Dermavant Investigative Site

Waterloo, Ontario, N2J 1C4, Canada
Dermavant Investigative Site

Windsor, Ontario, N8W 1E6, Canada

Conditions

Explore the condition pages connected to this study.

ATOPIC DERMATITIS